IUCT-Oncopole & Artios join forces to overcome resistance to therapies for familial breast cancer
| Press release
News & Events
Leaders at Artios explore the potential of expanding therapeutic opportunities in DDR beyond synthetic lethality
| Media coverage
Scientists uncover novel DNA repair mechanism for key cancer target
| Media coverage
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer
| Press release
Benchtop Bios Podcast featuring Dr. Graeme Smith
| Media coverage
Artios Appoints Samantha Truex to Board of Directors
| Press release
